Arch Biopartners Inc (ARCH)

Currency in CAD
1.65
0.00(0.00%)
Closed·
ARCH Scorecard
Full Analysis
Net income is expected to drop this year
ARCH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.651.67
52 wk Range
1.272.20
Key Statistics
Bid/Ask
1.65 / 1.66
Prev. Close
1.65
Open
1.66
Day's Range
1.65-1.67
52 wk Range
1.27-2.2
Volume
42.9K
Average Volume (3m)
32.35K
1-Year Change
10%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARCH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Arch Biopartners Inc Company Profile

Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin related acute kidney injury via dipeptidase-1. The company also develops AB569 for treating antibiotic-resistant bacterial infections and as a topical treatment for wounds; and Borg, a peptide-solid surface interface, which are binding of proprietary peptides to solid metal and plastic surfaces to inhibit biofilm formation and to reduce corrosion. Arch Biopartners Inc. is based in Toronto, Canada.

0
Market
Canada

Compare ARCH to Peers and Sector

Metrics to compare
ARCH
Peers
Sector
Relationship
P/E Ratio
−44.0x−6.7x−0.6x
PEG Ratio
−5.540.010.00
Price/Book
−28.7x1.2x2.6x
Price / LTM Sales
−1,240.4x1.2x3.3x
Upside (Analyst Target)
-103.8%37.7%
Fair Value Upside
Unlock15.7%3.9%Unlock

Earnings

Latest Release
Sep 02, 2025
EPS / Forecast
-0.004 / -0.02
Revenue / Forecast
158.08K / --
EPS Revisions
Last 90 days

ARCH Income Statement

FAQ

What Stock Exchange Does Arch Biopartners Trade On?

Arch Biopartners is listed and trades on the TSX Venture Exchange stock exchange.

What Is the Stock Symbol for Arch Biopartners?

The stock symbol for Arch Biopartners is "ARCH."

What Is the Arch Biopartners Market Cap?

As of today, Arch Biopartners market cap is 102.03M.

What Is Arch Biopartners's Earnings Per Share (TTM)?

The Arch Biopartners EPS (TTM) is -0.04.

When Is the Next Arch Biopartners Earnings Date?

Arch Biopartners will release its next earnings report on 02 Feb 2026.

From a Technical Analysis Perspective, Is ARCH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Arch Biopartners Stock Split?

Arch Biopartners has split 1 times.

How Many Employees Does Arch Biopartners Have?

Arch Biopartners has 0 employees.

What is the current trading status of Arch Biopartners (ARCH)?

As of 09 Sept 2025, Arch Biopartners (ARCH) is trading at a price of 1.65, with a previous close of 1.65. The stock has fluctuated within a day range of 1.65 to 1.67, while its 52-week range spans from 1.27 to 2.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.